Endurant Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-354,721
Closed -$2.45M 77
2021
Q3
$2.45M Buy
354,721
+93,954
+36% +$649K 0.56% 37
2021
Q2
$2.12M Buy
260,767
+23,111
+10% +$188K 0.58% 46
2021
Q1
$3.71M Buy
+237,656
New +$3.71M 0.97% 36